www.fdanews.com/articles/75307-axcan-announces-third-quarter-2005-results
AXCAN ANNOUNCES THIRD QUARTER 2005 RESULTS
August 12, 2005
Axcan Pharma Inc. (AXP.TO: Quote, Profile, Research) (AXCA.O: Quote, Profile, Research), which specializes in gastrointestinal treatments, said on Thursday its quarterly profit fell 67 percent due in part to higher research, selling and administration costs. The Quebec-based firm said it had net profit of $4.1 million, or 9 cents a share, for the quarter ended June 30. That is down from profit of $12.6 million, or 25 cents a share, in the prior-year period.